Related Experiment Video
Updated: Mar 23, 2026

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
Cystatin C is Associated With Plaque Phenotype and Plaque Burden
Yufeng Wen1, Dan Xia, Yanchun Wang
1School of Public Health, Wannan Medical College, Wuhu, Anhui, China.
Insights
Serum cystatin C impacts carotid artery plaque stability differently based on kidney function. It may stabilize plaques with normal kidney function but predicts risk in mild impairment.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Biomarkers
Background:
- The interplay between carotid artery plaque characteristics and serum cystatin C levels across varying renal function statuses remains incompletely understood.
- Investigating this relationship is crucial for understanding atherosclerosis progression and cardiovascular risk.
Purpose of the Study:
- To elucidate the association between carotid artery plaque burden, plaque phenotype, and serum cystatin C levels in patients with normal and impaired renal function.
- To determine if serum cystatin C acts as a risk factor or protective marker in different renal function categories.
Main Methods:
- A cross-sectional study involving 1,477 patients, collecting demographic data, carotid ultrasonography, and serum cystatin C levels.
- Statistical analysis stratified by renal function (normal vs. mild impairment) to assess the relationship between serum cystatin C and carotid plaque burden/phenotype.
Main Results:
- Serum cystatin C was a risk factor for stable carotid plaque in patients with normal renal function (OR=2.05).
- In mild renal impairment, serum cystatin C was a risk factor for both stable (OR=1.60) and unstable plaques (OR=1.21).
- A nonlinear relationship was observed between serum cystatin C and plaque burden, with increasing burden noted when cystatin C levels ranged from 0.75-1.30 mg/L.
Conclusions:
- Serum cystatin C may promote plaque stability in individuals with normal renal function.
- In patients with mildly impaired renal function, serum cystatin C serves as a significant risk predictor for both stable and unstable carotid plaques.
- These findings highlight the differential role of serum cystatin C in carotid atherosclerosis based on renal function status.
Background/Aims:
The relationship between carotid artery plaque burden, phenotype and serum cystatin C at normal and impaired renal function is still unclear.
Methods:
Demographic characteristics, carotid ultrasonography and other relevant information of 1,477 patients were collected. The association of carotid artery plaque burden, plaque phenotype with serum cystatin C was evaluated by strategy analysis based on renal function.
Results:
Serum cystatin C (OR=2.05, 95% CI: 1.83-2.29, P<.01) was a risk factor of stable plaque among patients with normal glomerular filtration rate. However, in the patients with mild impaired renal function, serum cystatin C was not only a risk factor for stable plaque (OR=1.60, 95% CI: 1.43-1.78, P<.001) but also was a risk factor for unstable plaque (OR=1.21, 95% CI: 1.10-1.32, P<.001). The smoothing function curve and a three-piecewise linear regression revealed that a nonlinear relationship was observed between serum cystatin C and plaque burden. When serum cystatin C was in the range of 0.75-1.30 (mg/L), the plaque burden tended to increase.
Conclusion:
In normal renal function, serum cystatin C may confer stability of plaques. In mildly impaired renal function, serum cystatin C is a risk predictor of plaques. In normal renal function circumstances, serum cystatin C may benefit to the stability of plaques. In mild impaired renal function circumstances, serum cystatin C are a risk predictors of plaques.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Atherosclerosis I: Introduction
Cytoskeletal Linker Proteins - Plakins
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Lysosomal Hydrolases

